| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 05/03/2007 | WO2006127203A3 Methods of synthesizing 6-alkylaminoquinoline derivatives |
| 05/03/2007 | US20070099960 Liver X receptors (LXR) modulators such as 1-[[4-(1,1-dimethylethyl)phenyl]sulfonyl]-4-methoxy-N-(2-phenyl ethyl)-2,3-dihydro-1H-)indole-2-carboxamide, used for the treatment of atherosclerosis, dyslipidemia, obesity, diabetes, hypercholesterolemia, neurodegenerative diseases and inflammatory diseases |
| 05/03/2007 | US20070099956 Nitrogen-containing heterocyclic derivatives having 2, 6-disubstituted styryl |
| 05/03/2007 | US20070099950 Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain |
| 05/03/2007 | US20070099922 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide |
| 05/03/2007 | US20070099873 Quinolines useful as modulators of ion channels |
| 05/02/2007 | EP1780202A1 Quinoline derivative and insecticide containing same as active constituent |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1778658A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 05/02/2007 | EP1778638A1 Diaryl ether beta2 adrenergic receptor agonists |
| 05/02/2007 | EP1778624A1 Tyrosine derivatives as ppar-gamma-modulators |
| 05/02/2007 | EP1778233A1 Intracellular receptor modulator compounds and methods |
| 05/02/2007 | EP1778231A1 Chemical compounds |
| 05/02/2007 | EP1341542B1 Indanylderivatives for treating airway diseases |
| 05/02/2007 | CN1956961A Stable crystal form of 4-oxoquinoline compound |
| 05/02/2007 | CN1956960A Substituted quinoline derivatives as mitotic kinesin inhibitors |
| 05/02/2007 | CN1955175A Cumarin derivative and its preparation method and its drug composite and use |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/01/2007 | US7211695 Trans-1,4-bis{N-[2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethyl]amino}cyclohexane from aminating a dihydroxymethyl phenyl ketone with a diaminophenylene compound and a reducing agent; treating respiratory diseases, asthma, bronchitis, nervous system injury, premature labor |
| 05/01/2007 | US7211672 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 05/01/2007 | US7211588 N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation |
| 05/01/2007 | CA2283587C Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with n- or c-linked imidazoles |
| 04/26/2007 | WO2007045893A2 Beta adrenergic receptor pharmacophore |
| 04/26/2007 | WO2007045551A2 Renin inhibitors nitroderivatives |
| 04/26/2007 | US20070093525 Microsomal triglyceride transfer protein (MTP) inhibitor (S)-2-[(4'-Isopropoxybiphenyl-2-carbonyl)amino]quinoline-6-carboxylic acid {[(4-fluoro-benzyl)methylcarbamoyl]phenylmethyl}amide; treating obesity |
| 04/26/2007 | US20070093478 Novel mycobacterial inhibitors |
| 04/26/2007 | US20070093476 Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/26/2007 | US20070092467 Oxyacetamide compounds useful for stimulating or inducing the growth and/or retarding the loss of keratin fibers |
| 04/26/2007 | CA2626568A1 Renin inhibitors nitroderivatives |
| 04/26/2007 | CA2625287A1 Crystals of laquinimod sodium, and process for the manufacture thereof |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1776344A2 Quinoline derivatives as neurokinin receptor antagonists |
| 04/25/2007 | EP1776343A1 Quinoline derivatives as neurokinin receptor antagonists |
| 04/25/2007 | EP1776119A1 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators |
| 04/25/2007 | EP1675593A4 Process for making sterile aripiprazole of desired mean particle size |
| 04/25/2007 | EP1631533A4 Novel process for stereoselective reduction of beta-ketoesters |
| 04/25/2007 | EP1567500B1 Resolution of mefloquine with o,o-di-p-aroyltartaric acid |
| 04/25/2007 | CN1951937A Process for preparing argatroban hydrate |
| 04/25/2007 | CN1951936A Argatroban separation method |
| 04/25/2007 | CN1951920A Process for preparing 4-(4-fluoro-phenyl)-3- hydroxymethyl-2- cyclopropyl-quinoline |
| 04/25/2007 | CN1951917A Pyridinone derivatives for treatment of atherosclerosis |
| 04/25/2007 | CN1312131C Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent |
| 04/25/2007 | CN1312116C Calcium acceptor active compound |
| 04/24/2007 | US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2007 | US7208623 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
| 04/24/2007 | CA2131644C Quinoline compounds |
| 04/24/2007 | CA2075173C Compounds and methods for inhibition of hiv and related viruses |
| 04/19/2007 | WO2007042325A1 Antibacterial active 5-chinolin derivative |
| 04/19/2007 | WO2007005887A3 Androgen receptor modulator compounds, compositions and uses thereof |
| 04/19/2007 | WO2006101217A3 Luminous compound containing lanthanide ion |
| 04/19/2007 | WO2006040178A9 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor |
| 04/19/2007 | US20070088163 Modulators of calcitonin and amylin activity |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | CA2625687A1 Antibacterial active 5-chinolin derivative |
| 04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 04/18/2007 | EP1773816A2 Modulators of atp-binding cassette transporters |
| 04/18/2007 | EP1773802A1 Enantioselective method for separing substituted 2-trifluoromethyl-2h-chromene-3-carboxylic acid derivatives |
| 04/18/2007 | EP1773774A2 Heterocyclic acetophenone potentiators of metabotropic glutamate receptors |
| 04/18/2007 | EP1773773A1 Amido compounds and their use as pharmaceuticals |
| 04/18/2007 | EP1773763A1 Lysine based compounds |
| 04/18/2007 | EP1773756A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/18/2007 | EP1442032B1 Heterocyclic retinoid compounds |
| 04/18/2007 | CN1950356A Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 04/18/2007 | CN1950340A LXR receptor modulators |
| 04/18/2007 | CN1950081A Arylalkylamino-substituted quinazoline analogues |
| 04/18/2007 | CN1948306A Fluoroquinolone-oxazolidone derivative, its preparation method and application |
| 04/18/2007 | CN1948290A Preparation method of 5,6,7,8-tetrahydroquinoline |
| 04/18/2007 | CN1310889C Halogen-substituted quinoline derivatives and ectoparasite control agent |
| 04/17/2007 | US7205409 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomoderators |
| 04/17/2007 | US7205408 Therapy for bacteria infections in mammals |
| 04/17/2007 | US7205320 Such as 3-[3-(4-chlorophenyl)prop-1-yloxy]-4-methoxy-N-(3-pyridylmethyl)diphenylamine; reduced emetic side effect; neurological syndromes |
| 04/17/2007 | US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis |
| 04/17/2007 | US7205299 Indole derivatives having an apoptosis-inducing effect |
| 04/17/2007 | US7205054 Metal coordination compound, luminescence device and display apparatus |
| 04/17/2007 | CA2341690C Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 04/17/2007 | CA2290549C Anti-helicobacter pylori pharmaceutical composition |
| 04/12/2007 | WO2007041414A1 Methods of preparing anhydrous aripiprazole form ii |
| 04/12/2007 | WO2007041076A2 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | WO2007040240A1 Optically active cyclic alcohol compound and method for producing same |
| 04/12/2007 | WO2007040238A1 Process for production of optically active 4-hydroxy-1,2,3,4 -tetrahydroquinolines |
| 04/12/2007 | WO2007039238A1 Novel chemical process for the synthesis of quinoline compounds |
| 04/12/2007 | WO2007039220A1 Novel quinoline compounds capable of binding at the cb2 receptor |
| 04/12/2007 | WO2007039219A1 Quinoline compounds capable of binding the cb2 and/or the 5-ht6 receptor |
| 04/12/2007 | WO2007038865A1 Substituted quinolines as inhibitors of leukotriene biosynthesis |
| 04/12/2007 | WO2007008942A3 Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases |
| 04/12/2007 | WO2006128802A3 3-methanesulfonylquinolines as gaba-b enhancers |
| 04/12/2007 | WO2006124692A3 3-cyanoquinoline inhibitors of tpl2 kinase and methods of making and using the same |
| 04/12/2007 | US20070082925 Method for the preparation of montelukast acid and sodium salt thereof in amorphous form |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | US20070082896 4-{[3,5-Bis(trifluoromethyl)benzyl]-[5-(4-carboxybutoxy)pyrimidin-2-yl]}amino-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester; cholesteryl ester transfer protein (CETP) inhibitors; increasing HDL cholesterol; lowering LDL cholesterol; arteriosclerosis, hyperlipidemia |
| 04/12/2007 | US20070082874 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/12/2007 | CA2624357A1 Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2624345A1 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2624294A1 Substituted quinolines as inhibitors of leukotriene biosynthesis |
| 04/12/2007 | CA2624269A1 Exemestane compounds, compositions and related uses thereof |
| 04/11/2007 | EP1772142A2 Organic compounds |
| 04/11/2007 | EP1771456A2 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 04/11/2007 | EP1771421A1 N-hydroxyamide derivatives and use thereof |
| 04/11/2007 | EP1771167A2 Histone deacetylase inhibitors |
| 04/11/2007 | EP1480972B1 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |